Search Results 201-210 of 16487 for Pulmonary hypertension
... pulmonary arterial hypertension (PAH). Pulmonary rehabiltation has been shown to be an effective treatment for patients with chronic obstructive pulmonary ...
A Study to Determine if Early Changes of Pulmonary Artery Hypertension can be Seen by Adding Exercise During Cardiac Magnetic Resonance Imaging (MRI).
Hepatopulmonary Syndrome and Portopulmonary Hypertension: Pulmonary Vascular Complications of Liver Disease. Compr Physiol. 2021 Oct 12; 11 (4):3281-3302
Pulmonary embolism, Hereditary hemorrhagic telangiectasia, Hepatopulmonary syndrome, Pulmonary hypertension, Portopulmonary hypertension, Pulmonary ...
Occupational or environmental lung disease; Post-thoracic surgery; Pulmonary fibrosis · Pulmonary hypertension; Respiratory failure; Sarcoidosis. The Pulmonary ...
... Pulmonary Hypertension groups. PVR is an excellent surrogate marker for pulmonary vasodilation and has been used in previous early trials of PH therapy.
Pulmonary vascular disease. Specific areas of interest include pulmonary hypertension, hereditary hemorrhagic telangiectasia, portopulmonary hypertension and ...
High blood pressure in the lungs, also called pulmonary hypertension. Pulmonary hypertension can increase pressure in the right ventricle. This can cause ...
The purpose of this study is to assess known gene variants in a patient with associated pulmonary arterial hypertension (PAH) due to scleroderma who is ...
The purpose of this study is to evaluate the prevalence and effect of frailty in patients referred to pulmonary hypertension (PH) clinic at our institution.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.